We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

201 hedge funds and large institutions have $917M invested in Editas Medicine in 2019 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 65 increasing their positions, 46 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

41% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 46

29% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 28

18% more capital invested

Capital invested by funds: $780M → $917M (+$137M)

4.25% more ownership

Funds ownership: 72.11% → 76.36% (+4.3%)

4% more funds holding

Funds holding: 194 → 201 (+7)

73% less call options, than puts

Call options by funds: $7.03M | Put options by funds: $26.5M

Holders
201
Holders Change
+7
Holders Change %
+3.61%
% of All Funds
4.35%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
36
Increased
65
Reduced
46
Closed
28
Calls
$7.03M
Puts
$26.5M
Net Calls
-$19.5M
Net Calls Change
-$21.6M

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$34.7M
2
NAMA
Nikko Asset Management Americas
New York
+$16.7M
3
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$16.3M
4
State Street
State Street
Massachusetts
+$15.9M
5
GLA
Great Lakes Advisors
Illinois
+$6.25M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.5M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$5.37M
3
JCM
JS Capital Management
New York
-$4.98M
4
UBS AM
UBS AM
Illinois
-$3.8M
5
Capital International Investors
Capital International Investors
California
-$3.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
CWM
176
Catamount Wealth Management
Connecticut
$4K -$3.4K -150 -50%
AF
177
Advisornet Financial
Minnesota
$4K – – –
AA
178
AlphaMark Advisors
Kentucky
$4K – – –
BWP
179
Baldwin Wealth Partners
Massachusetts
$4K – – –
CFGS
180
Concourse Financial Group Securities
Alabama
$4K – – –
RFC
181
Regions Financial Corp
Alabama
$4K +$3.46K +153 New
RCAG
182
Rehmann Capital Advisory Group
Michigan
$3.45K – – –
CCM
183
Cribstone Capital Management
Maine
$3K – – –
S
184
SignatureFD
Georgia
$3K – – –
WAP
185
Wealthcare Advisory Partners
Pennsylvania
$3K – – –
PA
186
Parallel Advisors
California
$3K +$2.38K +105 New
AA
187
Advisory Alpha
Michigan
$2.46K +$2.26K +100 New
TCM
188
Tradewinds Capital Management
Washington
$2K -$4.01K -177 -64%
CFD
189
Creative Financial Designs
Indiana
$2K -$2.26K -100 -50%
GAM
190
Gemmer Asset Management
California
$2K – – –
LF
191
Lee Financial
Texas
$2K – – –
LC
192
Lindbrook Capital
California
$2K – – –
BBNA
193
Bremer Bank National Association
Minnesota
$2K +$2.26K +100 New
GEA
194
Glen Eagle Advisors
New Jersey
$1.83K – – –
ASN
195
Advisory Services Network
Georgia
$1K – – –
PAI
196
Pittenger & Anderson Inc
Nebraska
$1K – – –
JPLA
197
Joseph P. Lucia & Associates
New York
$65 +$40.1K +1,770 New
GT
198
Glenmede Trust
Pennsylvania
$42 – – –
JCM
199
JS Capital Management
New York
– -$4.98M -218,935 Closed
Capital International Investors
200
Capital International Investors
California
– -$3.46M -152,000 Closed
5 6 7
8
9

EDIT Hedge Fund Activity: Q1 2019 in Review

201 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2019, worth a combined $917M — up 18% from $780M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new EDIT positions and 28 closed out — a net gain of 8 holders — while 65 added to existing stakes and 46 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $34.7M. The largest seller was Fidelity Investments, cutting an estimated $11.5M.

  • 201 institutional investors held Editas Medicine (EDIT) as of Q1 2019, up from 194 in Q4 2018.
  • Funds reported $917M of Editas Medicine stock for Q1 2019, up 18% quarter-over-quarter.
  • 36 funds opened new Editas Medicine positions in Q1 2019 and 28 closed out, a net change of +8 holders.
  • The largest Editas Medicine buyer in Q1 2019 was ARK Investment Management, an estimated $34.7M added.
  • The largest Editas Medicine seller in Q1 2019 was Fidelity Investments, an estimated $11.5M sold.

Based on aggregated 13F filings for Q1 2019.